Cybin is a biotech company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions.

Biotechnology

Cybin

Greg Cavers

Alex Nivorozhkin

Robert Mino

Geoff Varty

Gabe F.

Kristen Irizarry

Ryan Richardson

Kenneth Avery

Angela Sorie

Ellen James

Alex Kelly

Aaron Bartlone

Stephen Gorny

Jessica Leitner

Sarah Hamilton

Rachel Y.

Erica Olson Cpa, Ca

Erica Olson

Kathy Dorsey

Meghan Good

Victoria Attwooll

Liz Galic

Lisa Salazar

Erik Stang

Pradip Pathare

Emma Hodge

Lori Challenger

Bill Brennan

Catherine Schon

Eric Hoskins

Grant Froese

Lynn Marie Morski

Maurizio Fava

Sherri M. Altshuler

Thomas Laughren

John Kanakis

Mark Lawson

Anthony Back

Theresa Firestone

The Leadership Team at Cybin is responsible for setting strategic direction, guiding operational excellence, and overseeing the development and commercialization of innovative psychedelic pharmaceutical treatments. This diverse group of executives collaborates to ensure compliance with regulatory standards, drive scientific research, and foster partnerships that enhance the company's mission to improve mental health outcomes. Through their combined expertise, the team shapes Cybin's vision and growth in the biotech industry.

Leadership Team

The Clinical and Regulatory Team at Cybin is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of psychedelic pharmaceutical treatments. They ensure compliance with regulatory standards, manage the transition between phases of clinical development, and collaborate with advisors to guide the company's clinical strategy. Their work is essential for advancing Cybin's innovative therapies for psychiatric and neurological conditions.

Clinical and Regulatory Team

The Legal and Compliance team at Cybin is responsible for ensuring that the company adheres to all regulatory requirements and ethical standards in the development and commercialization of its psychedelic pharmaceutical treatments. This team handles legal matters, intellectual property rights, compliance protocols, and corporate governance, providing vital support to safeguard the company’s interests while fostering innovation in psychiatric and neurological healthcare.

Legal and Compliance

The Research and Development team at Cybin focuses on innovating and optimizing psychedelic pharmaceutical treatments, conducting rigorous scientific studies, and developing advanced manufacturing processes. With expertise in chemistry and biopharmaceutical development, the team collaborates to design, synthesize, and evaluate novel therapeutic compounds aimed at addressing psychiatric and neurological disorders.

Research and Development

The Finance and Accounting Team at Cybin is responsible for managing the company’s financial health and integrity. This team oversees budgeting, forecasting, and financial reporting, ensuring compliance with regulatory standards while supporting strategic decision-making. They analyze financial data to guide investments in innovative psychedelic therapies and optimize resource allocation for ongoing research and development initiatives.

Finance and Accounting Team

The Clinical Operations Team at Cybin oversees the planning, execution, and management of clinical trials for psychedelic pharmaceutical treatments. This team ensures compliance with regulatory standards, coordinates between facilitators and researchers, and evaluates the effectiveness of therapeutic interventions to advance the development of innovative therapies for psychiatric and neurological conditions.

Clinical Operations Team

Cybin

Org chart

Board & advisors

Teams

Leadership Team

Clinical and Regulatory Team

Legal and Compliance

Research and Development

Finance and Accounting Team

Clinical Operations Team

Offices

Cybin

Org chart

Board & advisors

Teams

Leadership Team

Clinical and Regulatory Team

Legal and Compliance

Research and Development

Finance and Accounting Team

Clinical Operations Team

Offices

Related companies